Programme

Take a look at the interactive multi-stream agenda for HPE LIVE 2017 below. For more information on what will be discussed in each individual session, simply click on the stream title at the top of the agenda. If you would like more details on the speaker, their biography can be viewed by clicking on that speakers name.

To navigate back to the full agenda click on the grey “Full Agenda” square on the top left.

Delegates are welcome to move freely between the streams during the day.

09:00

Registration Opens

09:40

Chair's Opening Remarks

  • Kandarp Thakkar, Chief Pharmacist & Divisional Clinical Director (Planned Care), Bedford Hospital NHS Trust

Chair's Opening Remarks

  • Sotiris Antoniou, Consultant Pharmacist, Cardiovascular Medicine, Barts Health NHS Trust Lead Pharmacist for UCL Partners, AHSN

Chair's Opening Remarks

  • Christine Clark, Editor of Hospital Pharmacy Europe, freelance medical writer and pharmacy consultant specialising in dermatology

Chair's Opening Remarks

  • Aisling Considine, Consultant Hepatology Pharmacist, Liver Pharmacy Team Leader and Honorary Clinical Lecturer, Kings College Hospital (KCH) NHS Foundation Trust

Chair's Opening Remarks

  • Laurence Goldberg, Independent pharmaceutical consultant and editorial consultant, Hospital Pharmacy Europe
10:00

Biosimilars an NHS perspective

  • Margaret Dolan, Specialist Procurement Pharmacist, NHS Commercial Solutions

Saving lives and strokes with appropriate oral anticoagulation in atrial fibrillation

  • Liz Corteville, Medicines Optimisation Locality Lead Pharmacist, West Hampshire CCG

The changing landscape of eczema treatment

  • Christine Clark, Editor of Hospital Pharmacy Europe, freelance medical writer and pharmacy consultant specialising in dermatology

Liver disease: What can community services do to reduce its burden?

  • Jeremy Thompson, GP and Clinical Director, Bevan Healthcare; British Liver Trust/RCGP Clinical Champion for Liver Disease

Managing chemotherapy electronically from prescription to patient 

  • Brid Ryan, Aseptic Compounding Service Manager, Mater Misericordiae University Hospital, Dublin, Ireland and Honorary Clinical Lecturer, Royal College of Surgeons Ireland
10:40

Coffee Break

11:10

Changing the paradigm of treating serious skin infections

  • Dr John Cunniffe, Consultant in Medical Microbiology, Wirral University Teaching Hospital NHS Foundation Trust

Managing acute heart failure patients in hospital

  • Joanne Bateman, Deputy Pharmacy Clinical Services Manager/Lead Cardiology Pharmacist, The Countess of Chester Hospital NHS Foundation Trust

How pharmacists can improve outcomes for patients with psoriasis

  • Rod Tucker, Community Pharmacist and Research Associate, Robert Gordon University

Current thinking on inflammatory bowel disease

  • Anja St. Clair Jones, Consultant Pharmacist Gastroenterology, Brighton and Sussex University Hospitals NHS Trust

Safe compounding of hazardous drugs

  • John Landers, Medicines Assurance and Aseptic Services Manager Pharmacy Department, Salford Royal Hospital NHS Foundation Trust
11:55

Antimicrobial stewardship in practice

  • Dr Jacqueline Sneddon, Project Lead, Scottish Antimicrobial Prescribing Group, Healthcare Improvement Scotland

Anticoagulation: why, when and how to adjust DOAC doses

  • Terry Dowling, Principal Pharmacist, Haemostasis & Thrombosis, Guy’s & St. Thomas’ NHS Foundation Trust

Recommending the correct emollient

  • Ibrar Ahmed, Pharmacist and Commissioner, NHS Leeds South and East CCG

Recent advances in irritable bowel syndrome

  • Dr Adam Farmer, Consultant Gastroenterologist and Senior Lecturer University Hospitals of North Midlands

A performance testing protocol for closed system transfer devices used during pharmacy compounding and administration of hazardous drugs

  • Alan Wilkinson, Chief Executive Officer, Biopharma Stability Testing Laboratory (BSTL)
12:35

Lunch

13:25

Shortages of Medicines

  • Jane Nicholson, Working Group 3 Leader, COST Medicines Shortages Research Network

Best practice in treating stroke

  • Derek Taylor, Assistant Director of Pharmacy for Governance and Risk, Royal Liverpool and Broadgreen University Hospitals NHS Trust

Personalised medicine for the rheumatology patient

  • Hilary McKee, Consultant Pharmacist, Northern Health and Social Care Trust

Coeliac Disease: Gluten Free - the future is now!

  • Dr Peter Gillett, Consultant Paediatric Gastroenterologist, Royal Hospital for Sick Children, Edinburgh

Safe administration of hazardous drugs

  • Lesley Sheen, Nurse Consultant Chemotherapy, Colchester Hospital University NHS Foundation Trust
14:10

Improving effective anticoagulant therapy in VTE Care

  • Sharron Gordon, Pharmacist Consultant Anticoagulation, Managing Director Sharron Gordon Ltd

Better integrated care for diabetes patients: Getting the right care at the right time

  • Hannah Beba, Senior Pharmacist for Diabetes and Endocrinology, County Durham and Darlington NHS Foundation Trust

Biologic therapy in rheumatology

Perspectives in liver diseases- past, present and possibilities

  • Valerie Ross, Lead Pharmacist Hepatology, Barts Health NHS Trust

mAbs – Improving care and protecting staff

  • Ian Rudd, Director of Pharmacy, NHS Highland
14:50

Coffee break

15:15

Medication safety and opioids: safer by design

  • Dr Alice Oborne, Consultant Pharmacist-Medication Safety, and Medication Safety Officer, Guy’s and St Thomas’ NHS Foundation Trust

New drugs to treat diabetes

  • Sallianne Kavanagh, Lead Clinical Pharmacist Diabetes and Endocrinology, Sheffield Teaching Hospitals NHSFT

Delegates are welcome to attend co-located sessions

Hepatitis C – the yellow brick road to elimination

  • Sital Shah, Senior hepatology pharmacist, King’s College Hospital

Dose Banding – making it work in practice

  • Richard Nuttall, Electronic prescribing pharmacist, Royal Marsden NHS Foundation Trust
16:00

To Scan or not to scan   – Background to the EU Falsified Medicines Directive  (FMD)

  • Aileen Bryson, Practice and Policy Lead at Royal Pharmaceutical Society Scotland

Diabetes and ethnicity

  • Lubna Kerr, Senior Hospital Pharmacy Practitioner, NHS Lothian

Delegates are welcome to attend co-located sessions

Delegates are welcome to attend co-located sessions

Delegates are welcome to attend co-located sessions

16:40

Conference Ends

09:00

Registration Opens

09:40

Chair's Opening Remarks

Speaker(s):
  • Kandarp Thakkar, Chief Pharmacist & Divisional Clinical Director (Planned Care), Bedford Hospital NHS Trust, ,
10:00

Biosimilars an NHS perspective

  • What are the opportunities/challenges.
  • Stakeholder engagement.
  • Analysis of uptake.
Speaker(s):
  • Margaret Dolan, Specialist Procurement Pharmacist, NHS Commercial Solutions, ,
10:40

Coffee Break

11:10

Changing the paradigm of treating serious skin infections

  • What do we do with patients who are unable, unsuitable or unwilling to receive therapy either in hospital or through OPAT services
  • Can drug interventions be used to free up capacity challenges
  • Where, when and why we break from the norm
Speaker(s):
  • Dr John Cunniffe, Consultant in Medical Microbiology, Wirral University Teaching Hospital NHS Foundation Trust, ,
11:55

Antimicrobial stewardship in practice

  • Antimicrobial stewardship is a key intervention to address the escalating global threat of antimicrobial resistance.
  • Many hospitals have established antimicrobial stewardship programmes and pharmacists have an important role to play in both leading and supporting this work.
  • A range of stewardship interventions including surveillance of antimicrobial use, quality improvement initiatives and education of healthcare staff can be used to optimise prescribing practice.
Speaker(s):
  • Dr Jacqueline Sneddon, Project Lead, Scottish Antimicrobial Prescribing Group, Healthcare Improvement Scotland, , Glasgow
12:35

Lunch

13:25

Shortages of Medicines

• The main reasons for medicines shortages and where in the supply chain they occur

• What has been done so far to engage manufacturers, wholesalers, parallel traders and government representatives with the problems of community and hospital pharmacists

• Discuss how to reduce medicines shortages and minimise the adverse effect of shortages on patients

Speaker(s):
  • Jane Nicholson, Working Group 3 Leader, COST Medicines Shortages Research Network, Industrial Pharmacists Group, Slough
14:10

Improving effective anticoagulant therapy in VTE Care

  • Putting guidelines into practice.
  • Managing challenging patient populations.
  • Making care safe and streamlined.
Speaker(s):
  • Sharron Gordon, Pharmacist Consultant Anticoagulation, Managing Director Sharron Gordon Ltd, , Easton, Hampshire
14:50

Coffee break

15:15

Medication safety and opioids: safer by design

  • The session will include
  • A designing for safety approach to safer use of opioid patches
  • Use of electronic systems to reduce medication formulation errors
  • What we have learned during attempts to spread practice
Speaker(s):
  • Dr Alice Oborne, Consultant Pharmacist-Medication Safety, and Medication Safety Officer, Guy’s and St Thomas’ NHS Foundation Trust, , London
16:00

To Scan or not to scan   – Background to the EU Falsified Medicines Directive  (FMD)

  • FMD – The  basics
  • The clock is ticking
  • Brexit and the FMD
Speaker(s):
  • Aileen Bryson, Practice and Policy Lead at Royal Pharmaceutical Society Scotland, ,
16:40

Conference Ends

09:00

Registration Opens

09:40

Chair's Opening Remarks

Speaker(s):
  • Sotiris Antoniou, Consultant Pharmacist, Cardiovascular Medicine, Barts Health NHS Trust Lead Pharmacist for UCL Partners, AHSN, ,
10:00

Saving lives and strokes with appropriate oral anticoagulation in atrial fibrillation

  • Stopping the use of aspirin (or other antiplatelet monotherapy) for AF-stroke prevention in high-risk patients.
  • Optimising warfarin control in AF-related stroke prevention.
  • Initiating/changing to a DOAC in high-risk patients.
Speaker(s):
  • Liz Corteville, Medicines Optimisation Locality Lead Pharmacist, West Hampshire CCG, ,
10:40

Coffee Break

11:10

Managing acute heart failure patients in hospital

  • Overview of the management of acute Heart Failure
  • Considerations in complex patients
  • Monitoring and discharge planning of the HF patient
Speaker(s):
  • Joanne Bateman, Deputy Pharmacy Clinical Services Manager/Lead Cardiology Pharmacist, The Countess of Chester Hospital NHS Foundation Trust, , Chester
11:55

Anticoagulation: why, when and how to adjust DOAC doses

  • Recognise the importance of stroke prevention in people with NVAF
  • Identify appropriate treatment options for stroke prevention in NVAF
  • Understand why, when and how to adjust DOAC doses in NVAF
Speaker(s):
  • Terry Dowling, Principal Pharmacist, Haemostasis & Thrombosis, Guy’s & St. Thomas’ NHS Foundation Trust, ,
12:35

Lunch

13:25

Best practice in treating stroke

  • Outline best practice in the acute management of stroke patients.
  • Discuss the evidence base of secondary preventative medicines post-stroke.
  • Identify the role of pharmacy in the acute and ongoing management of stroke patients.
Speaker(s):
  • Derek Taylor, Assistant Director of Pharmacy for Governance and Risk, Royal Liverpool and Broadgreen University Hospitals NHS Trust, , Liverpool
14:10

Better integrated care for diabetes patients: Getting the right care at the right time

  • The concept of ‘case loading’ within the hospital.
  • Development of outreach services from the hospital.
  • Development of ‘specialist interest’ in diabetes in primary care and community pharmacy.
Speaker(s):
  • Hannah Beba, Senior Pharmacist for Diabetes and Endocrinology, County Durham and Darlington NHS Foundation Trust, , County Durham and Darlington
14:50

Coffee break

15:15

New drugs to treat diabetes

  • Introduction to the newer agents for the management of Type 2 Diabetes
  • Brief review of the evidence to support use of the new agents
  • Place in therapy when considering the application of NICE guidance
Speaker(s):
  • Sallianne Kavanagh, Lead Clinical Pharmacist Diabetes and Endocrinology, Sheffield Teaching Hospitals NHSFT, ,
16:00

Diabetes and ethnicity

  • Diabetes in South Asians;
  • Understanding cultural issues;
  • Model of care;
  • Stigma and prejudice;
Speaker(s):
  • Lubna Kerr, Senior Hospital Pharmacy Practitioner, NHS Lothian, , Edinburgh
16:40

Conference Ends

09:00

Registration Opens

09:40

Chair's Opening Remarks

Speaker(s):
  • Christine Clark, Editor of Hospital Pharmacy Europe, freelance medical writer and pharmacy consultant specialising in dermatology, , Lancashire
10:00

The changing landscape of eczema treatment

  • Eczema (atopic dermatitis) is associated with a defective skin barrier and immune dysfunction.
  • Inflammatory processes that drive eczema and new targets for therapeutic intervention.
  • How ‘traditional’ and new treatments such as dupilumab and crisaborole fit into the picture.
  • What this means in practice for treatment pathways and patient care.
Speaker(s):
  • Christine Clark, Editor of Hospital Pharmacy Europe, freelance medical writer and pharmacy consultant specialising in dermatology, , Lancashire
10:40

Coffee Break

11:10

How pharmacists can improve outcomes for patients with psoriasis

  • Psoriasis is a complex, multifactorial immune-mediated inflammatory condition.
  • Patients with psoriasis want, but rarely receive advice and support on how to use treatments.
  • Pharmacist-led educational advice can have a potential important impact on patient-related disease outcomes.
Speaker(s):
  • Rod Tucker, Community Pharmacist and Research Associate, Robert Gordon University, , Aberdeen, Scotland
11:55

Recommending the correct emollient

  • The role of emollients
  • How to pick the right emollient
  • How to maximise benefit from your emollient
Speaker(s):
  • Ibrar Ahmed, Pharmacist and Commissioner, NHS Leeds South and East CCG, ,
12:35

Lunch

13:25

Personalised medicine for the rheumatology patient

  • Predictors for severity of disease.
  • Choice of drug.
  • Complicating factors.
Speaker(s):
  • Hilary McKee, Consultant Pharmacist, Northern Health and Social Care Trust, , Antirm, Northern Ireland
14:10

Biologic therapy in rheumatology

  • Biologic therapy pathways.
  • Implementing biosimilars.
  • Biologic therapy dose reduction.
Speaker(s):
14:50

Coffee break

15:15

Delegates are welcome to attend co-located sessions

16:00

Delegates are welcome to attend co-located sessions

16:40

Conference Ends

09:00

Registration Opens

09:40

Chair's Opening Remarks

Speaker(s):
  • Aisling Considine, Consultant Hepatology Pharmacist, Liver Pharmacy Team Leader and Honorary Clinical Lecturer, Kings College Hospital (KCH) NHS Foundation Trust, ,
10:00

Liver disease: What can community services do to reduce its burden?

  • Morbidity and mortality due to liver disease are rising.
  • Up to 90% of liver disease is preventable.
  • Community services have a major role to play in its prevention.
Speaker(s):
  • Jeremy Thompson, GP and Clinical Director, Bevan Healthcare; British Liver Trust/RCGP Clinical Champion for Liver Disease, , Middlesbrough
10:40

Coffee Break

11:10

Current thinking on inflammatory bowel disease

  • Pharmacists can work as autonomous clinicians prescribing independently and safely, adding a unique skill to patient care
  • Pharmacists must get involved in all aspects of the long-term care
    • Enhancing patient safety
    • Standardising treatment & monitoring protocols
    • Individualising therapy particularly through TDM
  • Embedding pharmaceutical skills into the multidisciplinary team is essential
    • Influences therapeutic decision making early (attend MDT meetings)
    • Ensuring that services incorporate good medicine management
    • Medicine optimisation principles are observed at conception
Speaker(s):
  • Anja St. Clair Jones, Consultant Pharmacist Gastroenterology, Brighton and Sussex University Hospitals NHS Trust, , Sussex
11:55

Recent advances in irritable bowel syndrome

  • Irritable bowel syndrome is a chronic disorder characterised by abdominal pain coupled with a change in the form and/or frequency of stool. The predominant stool pattern can help subdivide the disorder into diarrhoea or constipation predominant or alternating IBS.
  • It is a common disorder, afflicting approximately 5% of the UK adult population.
  • Treatment is multifaceted but includes patient education.
  • New pharmacological interventions are developing and beginning to positively impact on patient outcomes.
Speaker(s):
  • Dr Adam Farmer, Consultant Gastroenterologist and Senior Lecturer University Hospitals of North Midlands, , London
12:35

Lunch

13:25

Coeliac Disease: Gluten Free - the future is now!

  • Gluten free diet still mainstay of treatment?
  • New therapies.
  • New controversies.
Speaker(s):
  • Dr Peter Gillett, Consultant Paediatric Gastroenterologist, Royal Hospital for Sick Children, Edinburgh, ,
14:10

Perspectives in liver diseases- past, present and possibilities

  • global public health burden
  • challenging diseases to manage
  • new and emerging treatment strategies, presenting exciting opportunities for pharmacists to contribute to care and cures.
Speaker(s):
  • Valerie Ross, Lead Pharmacist Hepatology, Barts Health NHS Trust, ,
14:50

Coffee break

15:15

Hepatitis C – the yellow brick road to elimination

  • Updates in treatment options
  • Challenges in testing and case finding
  • Delivery of treatment in the community
Speaker(s):
  • Sital Shah, Senior hepatology pharmacist, King’s College Hospital, , London
16:00

Delegates are welcome to attend co-located sessions

16:40

Conference Ends

09:00

Registration Opens

09:40

Chair's Opening Remarks

Speaker(s):
  • Laurence Goldberg, Independent pharmaceutical consultant and editorial consultant, Hospital Pharmacy Europe, ,
10:00

Managing chemotherapy electronically from prescription to patient 

  • The experience of implementing integrated prescribing, manufacture and administration of chemotherapy to ensure a closed loop system.
  • Benefits and challenges encountered.
  • How gravimetric manufacture of chemotherapy contributes to an aseptic compounding service.
Speaker(s):
  • Brid Ryan, Aseptic Compounding Service Manager, Mater Misericordiae University Hospital, Dublin, Ireland and Honorary Clinical Lecturer, Royal College of Surgeons Ireland, , Dublin
10:40

Coffee Break

11:10

Safe compounding of hazardous drugs

  • What are the risks to operators when compounding cytotoxics and who is at risk?
  • How can we practically manage these risks?
  • What monitoring should we be undertaking as part of the risk management process?
Speaker(s):
  • John Landers, Medicines Assurance and Aseptic Services Manager Pharmacy Department, Salford Royal Hospital NHS Foundation Trust, , Salford
11:55

A performance testing protocol for closed system transfer devices used during pharmacy compounding and administration of hazardous drugs

  • Selection of an appropriate challenge agent to use for testing CSTDs
  • Development of the test protocol in accordance with the draft NIOSH protocol
  • Validation of the test protocol
  • Interpretation of the experimental CSTD release data – what does it mean?

 

 

Speaker(s):
  • Alan Wilkinson, Chief Executive Officer, Biopharma Stability Testing Laboratory (BSTL), ,
12:35

Lunch

13:25

Safe administration of hazardous drugs

  • What are the risks to operators when compounding cytotoxics and who is at risk?
  • How can we practically manage these risks?
  • What monitoring should we be undertaking as part of the risk management process?
Speaker(s):
  • Lesley Sheen, Nurse Consultant Chemotherapy, Colchester Hospital University NHS Foundation Trust, , Colchester
14:10

mAbs – Improving care and protecting staff

  • NHS Highland has used closed system devices to prepare monoclonal antibodies to,
  • Improve the efficiency of its service to patients and staff
  • Improve the cost effectiveness of its service
  • Minimise risk to staff
Speaker(s):
  • Ian Rudd, Director of Pharmacy, NHS Highland, , Scotland
14:50

Coffee break

15:15

Dose Banding – making it work in practice

  • How do we dose band / methods used
  • Challenges of dose banding
  • Where to next?
Speaker(s):
  • Richard Nuttall, Electronic prescribing pharmacist, Royal Marsden NHS Foundation Trust, , London
16:00

Delegates are welcome to attend co-located sessions

16:40

Conference Ends



*Please note this programme is subject to change.

**We would like to thank our exhibitors for supporting this meeting, which includes a number of pharmaceutical companies. Unless stated in the programme, they have had no input into the agenda, speaker selection or content.